These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34278290)

  • 1. IgA Nephropathy After SARS-CoV-2 Vaccination.
    Abramson M; Mon-Wei Yu S; Campbell KN; Chung M; Salem F
    Kidney Med; 2021; 3(5):860-863. PubMed ID: 34278290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases.
    Yokote S; Ueda H; Shimizu A; Okabe M; Yamamoto K; Tsuboi N; Yokoo T
    CEN Case Rep; 2022 Nov; 11(4):499-505. PubMed ID: 35562631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination.
    Uchiyama Y; Fukasawa H; Ishino Y; Nakagami D; Kaneko M; Yasuda H; Furuya R
    BMC Nephrol; 2022 Jun; 23(1):216. PubMed ID: 35729514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine.
    Okada M; Kikuchi E; Nagasawa M; Oshiba A; Shimoda M
    CEN Case Rep; 2022 Aug; 11(3):376-379. PubMed ID: 35118635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary immunoglobulin A nephropathy with gross hematuria leading to rapidly progressive glomerulonephritis following severe acute respiratory syndrome coronavirus 2 vaccination: a case report.
    Fukuda M; Kaneko T; Kawai T; Ishii H; Shimizu A
    BMC Nephrol; 2023 Aug; 24(1):232. PubMed ID: 37553599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination.
    Fujita Y; Yoshida K; Ichikawa D; Shibagaki Y; Yazawa M
    CEN Case Rep; 2022 Aug; 11(3):302-308. PubMed ID: 34988883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gross hematuria can be an impact of severe acute respiratory syndrome coronavirus 2 vaccination on immunoglobulin A nephropathy: a case report.
    Kanamori H
    J Med Case Rep; 2022 Jul; 16(1):273. PubMed ID: 35818083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of renal histopathology in three patients with gross hematuria after SARS-CoV-2 vaccination.
    Ota K; Yonekura Y; Saigan M; Goto K; Nishi S
    CEN Case Rep; 2023 May; 12(2):176-183. PubMed ID: 36219335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal outcomes in IgA nephropathy following inactivated SARS-CoV-2 vaccination.
    Sun K; Shang D; Hao C; Lai L
    Clin Exp Nephrol; 2024 Jan; 28(1):23-30. PubMed ID: 37713044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection.
    Li H; Li Z; Wu Z; Wang F; Xing Y; Liu Y; Jia J; Yan T
    Clin Exp Med; 2024 Feb; 24(1):43. PubMed ID: 38400937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gross Hematuria Following SARS-CoV-2 Infection in IgA Nephropathy: A Report of 5 Cases.
    Ueda H; Okabe M; Shimizu A; Yokote S; Nakashima A; Tsuboi N; Ikeda M; Miyazaki Y; Yokoo T
    Kidney Med; 2023 Jun; 5(6):100627. PubMed ID: 37144236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses.
    Nam M; Yun SG; Kim SW; Kim CG; Cha JH; Lee C; Kang S; Park SG; Kim SB; Lee KB; Chung YS; Nam MH; Lee CK; Cho Y
    Microbiol Spectr; 2022 Aug; 10(4):e0249521. PubMed ID: 35946811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination.
    Nihei Y; Kishi M; Suzuki H; Koizumi A; Yoshida M; Hamaguchi S; Iwasaki M; Fukuda H; Takahara H; Kihara M; Tomita S; Suzuki Y
    Intern Med; 2022 Apr; 61(7):1033-1037. PubMed ID: 35110484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan.
    Matsuzaki K; Aoki R; Nihei Y; Suzuki H; Kihara M; Yokoo T; Kashihara N; Narita I; Suzuki Y
    Clin Exp Nephrol; 2022 Apr; 26(4):316-322. PubMed ID: 34773533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report.
    Morimoto N; Mori T; Shioji S; Taguchi T; Watanabe H; Sakai K; Mori K; Yamamura A; Hanioka A; Akagi Y; Fujiki T; Mandai S; Mori Y; Ando F; Susa K; Iimori S; Naito S; Sohara E; Ohashi K; Uchida S
    BMC Nephrol; 2023 Apr; 24(1):108. PubMed ID: 37095451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
    Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.